Throughout this medical market research, the publisher analyzed 46+ Orthobiologics companies in Europe and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.
While this report suite report contains all of the EU15 Orthobiologics market analysis, each of the market segments is also available as a stand-alone a report, MedCore.
Markets Covered
European Orthobiologics Market Insights
Overall, the orthopedic biomaterials market was valued at €401 million in 2020. This is expected to increase over the forecast period to reach €577 million in 2025.
A wider use of synthetic bone graft materials has been steadily reducing the amount of autograft bone that doctors have been using. Popularity of synthetics is due to their affordability and easy accessibility. Synthetic products are becoming the preferred choice over allografts, demineralized bone matrices and autografts. A wide range of synthetic products can offer flexibility and variety for different groups of patients.
Extensive research of hyaluronic acid has solidified Fidia Farmaceutici S.p.A.’s leading position in the lucrative HA market, and overall European Orthobiologics market. Fidia has increased their market share over the past few years, and a considerable amount of this expansion is due to Fidia’s expansion into the German market.
Report Regional Coverage
Throughout this research series, the publisher has covered several countries in great detail. The countries covered are:
While this report suite report contains all of the EU15 Orthobiologics market analysis, each of the market segments is also available as a stand-alone a report, MedCore.
Markets Covered
- Bone Graft Substitutes Market - MedCore
- Growth Factors Market - MedCore
- Orthopedic Cell Therapy Devices Market - MedCore
- Hyaluronic Acid Viscosupplementation Devices Market - MedCore
- Orthopedic Cartilage Repair Devices Market - MedCore
European Orthobiologics Market Insights
Overall, the orthopedic biomaterials market was valued at €401 million in 2020. This is expected to increase over the forecast period to reach €577 million in 2025.
A wider use of synthetic bone graft materials has been steadily reducing the amount of autograft bone that doctors have been using. Popularity of synthetics is due to their affordability and easy accessibility. Synthetic products are becoming the preferred choice over allografts, demineralized bone matrices and autografts. A wide range of synthetic products can offer flexibility and variety for different groups of patients.
Extensive research of hyaluronic acid has solidified Fidia Farmaceutici S.p.A.’s leading position in the lucrative HA market, and overall European Orthobiologics market. Fidia has increased their market share over the past few years, and a considerable amount of this expansion is due to Fidia’s expansion into the German market.
Report Regional Coverage
Throughout this research series, the publisher has covered several countries in great detail. The countries covered are:
- Germany
- France
- U.K.
- Italy
- Spain
- Benelux (Belgium, Netherlands, and Luxembourg)
- Scandinavia (Denmark, Finland, Norway, and Sweden)
- Switzerland
- Austria
- Portugal
Table of Contents
1. RESEARCH METHODOLOGY
2. IMPACT OF COVID-19 ON THE U.S. ORTHOPEDIC BIOMATERIALS MARKET
3. PRODUCT ASSESSMENT
4. U.S. ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW
5. PROCEDURE NUMBERS
6. ORTHOPEDIC BONE GRAFT SUBSTITUTE MARKET
7. ORTHOPEDIC GROWTH FACTOR MARKET
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Alphatec Spine
- Anika Therapeutics
- Arthrex
- Baxter
- Bioiberica
- Biomantle
- Bioventus
- BonAlive
- Cerapedics
- CO.DON
- Croma-Pharma
- Curasan
- Cytomedix
- DePuy Synthes
- Documedica
- Exactech
- Ferring
- Fidia Farmaceutici S.p.A.
- Finceramica
- Geistlich
- Harvest
- Integra Surgical
- Isto
- Kuros Biosciences
- Laboratoire Genevrier
- LCA Pharma
- Meda Pharmaceuticals
- Medtronic
- NovaBone
- NuVasive
- Orotech
- OsteoMed
- Ostetic
- Plasmaconcept AG
- Recordati
- Regenexx
- RTI Surgical
- Sanofi
- Seikagaku
- Stella Pharmaceuticals
- Stryker
- Tedec-Meiji
- TETEC
- TiGenix
- TRB Chemedica
- Wright Medical
- Zimmer Biomet
